Annual CFI
-$51.27 M
-$209.62 M-132.38%
December 1, 2024
Summary
- As of March 13, 2025, CCCC annual cash flow from investing activities is -$51.27 million, with the most recent change of -$209.62 million (-132.38%) on December 1, 2024.
- During the last 3 years, CCCC annual CFI has risen by +$138.07 million (+72.92%).
- CCCC annual CFI is now -132.38% below its all-time high of $158.35 million, reached on December 31, 2023.
Performance
CCCC Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$13.67 M
+$13.51 M+8338.27%
December 31, 2024
Summary
- As of March 13, 2025, CCCC quarterly cash flow from investing activities is $13.67 million, with the most recent change of +$13.51 million (+8338.27%) on December 31, 2024.
- Over the past year, CCCC quarterly CFI has increased by +$13.51 million (+8338.27%).
- CCCC quarterly CFI is now -76.32% below its all-time high of $57.73 million, reached on September 30, 2023.
Performance
CCCC Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$51.27 M
-$18.27 M-55.39%
December 31, 2024
Summary
- As of March 13, 2025, CCCC TTM cash flow from investing activities is -$51.27 million, with the most recent change of -$18.27 million (-55.39%) on December 31, 2024.
- Over the past year, CCCC TTM CFI has dropped by -$18.27 million (-55.39%).
- CCCC TTM CFI is now -132.38% below its all-time high of $158.35 million, reached on December 31, 2023.
Performance
CCCC TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
CCCC Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -132.4% | +8338.3% | -55.4% |
| 3 y3 years | +72.9% | +8338.3% | -55.4% |
| 5 y5 years | -3064.8% | +8338.3% | -55.4% |
CCCC Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -132.4% | +72.9% | -76.3% | +123.0% | -132.4% | +72.9% |
| 5 y | 5-year | -132.4% | +73.1% | -76.3% | +113.2% | -132.4% | +79.7% |
| alltime | all time | -132.4% | +73.1% | -76.3% | +113.2% | -132.4% | +79.7% |
C4 Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | $13.67 M(+8338.3%) | -$51.27 M(+55.4%) |
| Dec 2024 | -$51.27 M(-132.4%) | - | - |
| Sep 2024 | - | $162.00 K(-101.4%) | -$32.99 M(-234.3%) |
| Jun 2024 | - | -$11.71 M(-78.1%) | $24.57 M(-52.2%) |
| Mar 2024 | - | -$53.40 M(-267.1%) | $51.42 M(-67.5%) |
| Dec 2023 | $158.35 M(+171.0%) | $31.95 M(-44.7%) | $158.35 M(+16.7%) |
| Sep 2023 | - | $57.73 M(+281.1%) | $135.69 M(+38.6%) |
| Jun 2023 | - | $15.15 M(-71.7%) | $97.88 M(-15.6%) |
| Mar 2023 | - | $53.53 M(+476.6%) | $115.96 M(+98.5%) |
| Dec 2022 | $58.42 M | $9.28 M(-53.4%) | $58.42 M(-668.6%) |
| Sep 2022 | - | $19.91 M(-40.1%) | -$10.28 M(-92.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $33.23 M(-929.9%) | -$130.82 M(-0.6%) |
| Mar 2022 | - | -$4.00 M(-93.3%) | -$131.61 M(-30.5%) |
| Dec 2021 | -$189.34 M(-0.6%) | -$59.41 M(-41.0%) | -$189.34 M(+2.8%) |
| Sep 2021 | - | -$100.63 M(-410.3%) | -$184.09 M(+59.0%) |
| Jun 2021 | - | $32.43 M(-152.5%) | -$115.78 M(-54.1%) |
| Mar 2021 | - | -$61.73 M(+14.0%) | -$252.05 M(+32.3%) |
| Dec 2020 | -$190.50 M(>+9900.0%) | -$54.17 M(+67.6%) | -$190.50 M(+39.7%) |
| Sep 2020 | - | -$32.32 M(-68.9%) | -$136.34 M(+31.1%) |
| Jun 2020 | - | -$103.83 M(>+9900.0%) | -$104.02 M(>+9900.0%) |
| Mar 2020 | - | -$184.00 K | -$184.00 K |
| Dec 2019 | -$1.62 M(-104.4%) | - | - |
| Dec 2018 | $36.92 M | - | - |
FAQ
- What is C4 Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for C4 Therapeutics?
- What is C4 Therapeutics annual CFI year-on-year change?
- What is C4 Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for C4 Therapeutics?
- What is C4 Therapeutics quarterly CFI year-on-year change?
- What is C4 Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for C4 Therapeutics?
- What is C4 Therapeutics TTM CFI year-on-year change?
What is C4 Therapeutics annual cash flow from investing activities?
The current annual CFI of CCCC is -$51.27 M
What is the all time high annual CFI for C4 Therapeutics?
C4 Therapeutics all-time high annual cash flow from investing activities is $158.35 M
What is C4 Therapeutics annual CFI year-on-year change?
Over the past year, CCCC annual cash flow from investing activities has changed by -$209.62 M (-132.38%)
What is C4 Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of CCCC is $13.67 M
What is the all time high quarterly CFI for C4 Therapeutics?
C4 Therapeutics all-time high quarterly cash flow from investing activities is $57.73 M
What is C4 Therapeutics quarterly CFI year-on-year change?
Over the past year, CCCC quarterly cash flow from investing activities has changed by +$13.51 M (+8338.27%)
What is C4 Therapeutics TTM cash flow from investing activities?
The current TTM CFI of CCCC is -$51.27 M
What is the all time high TTM CFI for C4 Therapeutics?
C4 Therapeutics all-time high TTM cash flow from investing activities is $158.35 M
What is C4 Therapeutics TTM CFI year-on-year change?
Over the past year, CCCC TTM cash flow from investing activities has changed by -$18.27 M (-55.39%)